Skip to main content
Each ACT Signature Webinar offers an in-depth exploration of contemporary toxicology topics, presented by field experts with a broad range of professional backgrounds. Webinars consist of approximately 60 minutes of content, followed by a 30-minute live Q&A session, with both segments recorded for later access.

ACT Signature Webinars

Browse Search Sign in
Sign In

ACT Signature Webinars

ACT Signature Webinar series provides on-demand education to the toxicology community worldwide. These educational webinars cover current topics in toxicology and are presented by experts in the field, with backgrounds in government, industry, or academia.

Watch Now
Gift this

Each ACT Signature Webinar offers an in-depth exploration of contemporary toxicology topics, presented by field experts with a broad range of professional backgrounds. Webinars consist of approximately 60 minutes of content, followed by a 30-minute live Q&A session, with both segments recorded for later access.

  • Unlimited 7-Day Streaming Access

    Enjoy uninterrupted streaming of your selected content for a full 7 days.

  • Watch Anywhere

    Stream seamlessly on your favorite devices.

  • On-Demand Access

    Access expert-led webinars at your convenience.

Boost your knowledge at your own pace with ACT Signature Webinars.

  • ACT Signature Webinars
  • ACT Signature Webinars
  • ACT Signature Webinars
  • ACT Signature Webinars

 

Access Knowledge at Your Fingertips!

Learning at your convenience has never been easier!

Watch Now

$50 Rent

Buy from ACT Signature Webinars

  • Do we have to do a TQT clinical trial?
    Do we have to do a TQT clinical trial?
    1 video

    Do we have to do a TQT clinical trial?

    1 video

    June 11, 2025
    Speaker: Todd A. Wisialowski
    Educational Levels: Foundational, Practical

    ICH E14/S7B Q&As adopted in 2022 allow for an integrated risk assessment using nonclinical in vitro and in vivo data, together with results from early clinical trials, to inform the design of clinical investi...

  • The Past, Present, and Future of SEND
    The Past, Present, and Future of SEND
    1 video

    The Past, Present, and Future of SEND

    1 video

    March 12, 2024
    Speaker: Marc Ellison
    Educational Levels: Foundational, Practical

    Since the FDA's adoption of the Standard for Exchange of Nonclinical Data (SEND) in 2016, it has continuously evolved, expanding beyond general toxicology to include disciplines such as Development and Reproductive...

  • ICH S1B(R1): US FDA Perspectives on WoE Approach
    ICH S1B(R1): US FDA Perspectives on WoE Approach
    1 video

    ICH S1B(R1): US FDA Perspectives on WoE Approach

    1 video

    December 11, 2024
    Speakers: Timothy McGovern and Todd Bourcier
    Educational Levels: Advanced, Emerging

    The S1BR1 addendum expanded the evaluation process for assessing the human carcinogenic risk of pharmaceuticals. The addendum introduced a weight-of-evidence (WoE) approach to determine if a t...

View All

Watch on your Television

    • Learn More

Watch on your Computer

    • http://actsignaturewebinars.vhx.tv
    • Microsoft Edge 88+
    • Safari 13+
    • Firefox 78+
    • Chrome 71+
    • http://actsignaturewebinars.vhx.tv
About ACT Help Terms Privacy Cookies Sign in
 
×